TAL-T cells therapy(FineImmune Biotechnology)

N/A

Report date: 2024/03/11 20:05:20

Base Information

Drug NameTAL-T cells therapy(FineImmune Biotechnology)
Drug Alias NameTumor Associated Lymph node T cell therapy(FineImmune Biotechnology)Tumor-associated Lymph Node T Cell Therapy(FineImmune Biotechnology)FIT003FIT-003
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionT lymphocyte replacements
TargetsNot applicable
Therapy Area/IndicationsSolid tumoursLymphadenopathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesGuangzhou Fineimmune Biotechnology
China Registration ClassN/A

Develop Information

Active CompaniesGuangzhou Fineimmune Biotechnology
Inactive CompaniesN/A
Active IndicationsSolid tumoursLymphadenopathy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A